Authors
Loading...
In vitro study reveals interleukin-5 drives glycolysis and mitochondrial metabolism in human eosinophils, highlighting metabolic plasticity as a potential therapeutic target.
Jones et al. (2019) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: